Display options
Share it on

Indian J Clin Biochem. 2012 Jan;27(1):46-51. doi: 10.1007/s12291-011-0183-6. Epub 2012 Jan 06.

No Evidence for Mutations that Deregulate GARS-AIRS-GART Protein Levels in Children with Down Syndrome.

Indian journal of clinical biochemistry : IJCB

Disha Banerjee, Debarati Ghosh, Anindita Chatterjee, Swagata Sinha, Krishnadas Nandagopal

Affiliations

  1. Manovikas Biomedical Research and Diagnostic Centre, 482 Madudah, Plot I-24, Sector J, Eastern Metropolitan Bypass, Kolkata, 700 107 India.

PMID: 23277712 PMCID: PMC3286581 DOI: 10.1007/s12291-011-0183-6

Abstract

UNLABELLED: GARS-AIRS-GART is crucial in studies of Down syndrome (DS)-related mental retardation due to its chromosomal location (21q22.1), involvement in de novo purine biosynthesis and over-expression in fetal DS brain postmortem samples. GARS-AIRS-GART regions important for structure-function were screened for mutations that might alter protein levels in DS patients. Mutation screening relied on multiplex/singleplex PCR-based amplification of genomic targets followed by amplicon size determination/fingerprinting. Serum protein samples were resolved by SDS-PAGE and immunoblotted with a GARS-AIRS-GART monoclonal antibody. No variation in amplicon size/fingerprints was observed in regions encoding the ATP-binding, active site residues of GARS, the structurally important glycine-rich loops of AIRS, substrate-binding, flexible and folate-binding loops of GART or the poly-adenylation signal sequences. The de novo occurrence or inheritance of large insertion/deletion/rearrangement-type mutations is therefore excluded. Immunoblots show presence of GARS-AIRS-GART protein in all patient samples, with no change in expression levels with respect to either sex or developmental age.

ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12291-011-0183-6) contains supplementary material, which is available to authorized users.

Keywords: Down syndrome-related mental retardation; GARS–AIRS–GART; Immunoblot; Mutation screen; Survival

References

  1. J Clin Lab Anal. 2002;16(1):47-51 - PubMed
  2. Development. 1992 Jan;114(1):185-92 - PubMed
  3. Clin Chem. 2003 Oct;49(10):1679-82 - PubMed
  4. Hum Mol Genet. 2007 Apr 1;16(7):774-82 - PubMed
  5. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12031-6 - PubMed
  6. Mol Hum Reprod. 2000 May;6(5):391-6 - PubMed
  7. Proc Natl Acad Sci U S A. 1981 Jan;78(1):405-9 - PubMed
  8. Biochem Med Metab Biol. 1986 Aug;36(1):45-50 - PubMed
  9. Nucleic Acids Res. 1997 Aug 1;25(15):3118-23 - PubMed
  10. Prog Neurobiol. 1999 Dec;59(6):663-90 - PubMed
  11. Genetics. 2004 Dec;168(4):2011-23 - PubMed
  12. Amino Acids. 2003;24(1-2):119-25 - PubMed
  13. BMC Med Genet. 2006 Mar 15;7:24 - PubMed
  14. Curr Opin Chem Biol. 2000 Oct;4(5):567-72 - PubMed
  15. Hum Mol Genet. 1997 Nov;6(12):2043-50 - PubMed
  16. Genome Res. 2004 Jul;14(7):1258-67 - PubMed
  17. Biotechniques. 1997 Sep;23(3):504-11 - PubMed
  18. Gene. 2009 Jan 15;429(1-2):23-30 - PubMed
  19. Nucleic Acids Res. 1988 Feb 11;16(3):1215 - PubMed
  20. Nucleic Acids Res. 1988 Dec 9;16(23):11141-56 - PubMed
  21. Amino Acids. 2003;24(1-2):111-7 - PubMed
  22. Am J Ment Defic. 1969 Sep;74(2):196-9 - PubMed
  23. Science. 2008 Apr 4;320(5872):103-6 - PubMed
  24. Gene. 2005 Dec 30;364:90-8 - PubMed
  25. Nucleic Acids Res. 1990 Nov 25;18(22):6665-72 - PubMed
  26. Mol Biotechnol. 2009 Jul;42(3):306-19 - PubMed
  27. Am J Hum Genet. 1986 Aug;39(2):179-85 - PubMed
  28. Nat Rev Genet. 2009 Feb;10(2):83-93 - PubMed
  29. Nature. 2000 May 18;405(6784):311-9 - PubMed

Publication Types